OpenAI is acquiring Orchestra Bio to bring AI into life sciences R&DMachine translation
Automatically verified and published · Generated and evidence-checked automatically; not reviewed by a human.
OpenAI is acquiring Orchestra Bio and aims to bring AI-powered operations to life sciences R&D. Its stated goal is to help biopharma teams accelerate drug development and advance new treatments; those outcomes remain goals.
The complete source text is not yet available.
Read at the original source